tiprankstipranks
Amrutanjan Health Care Limited (IN:AMRUTANJAN)
:AMRUTANJAN
India Market
Want to see IN:AMRUTANJAN full AI Analyst Report?

Amrutanjan Health Care Limited (AMRUTANJAN) Ratios

1 Followers

Amrutanjan Health Care Limited Ratios

IN:AMRUTANJAN's free cash flow for Q2 2026 was ₹0.51. For the 2026 fiscal year, IN:AMRUTANJAN's free cash flow was decreased by ₹ and operating cash flow was ₹0.16. See a summary of the company’s cash flow.
Ratios
TTM
Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio
3.69 3.44 4.23 4.12 3.55
Quick Ratio
3.24 3.11 3.82 3.66 3.21
Cash Ratio
0.07 0.98 0.37 0.08 1.08
Solvency Ratio
0.70 0.61 0.65 0.63 0.84
Operating Cash Flow Ratio
0.14 0.60 0.40 0.30 0.67
Short-Term Operating Cash Flow Coverage
0.00 126.68 84.19 38.05 91.68
Net Current Asset Value
₹ 2.02B₹ 1.96B₹ 2.17B₹ 1.88B₹ 1.90B
Leverage Ratios
Debt-to-Assets Ratio
<0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
<0.01 <0.01 <0.01 <0.01 <0.01
Debt-to-Capital Ratio
<0.01 <0.01 <0.01 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.26 1.29 1.27 1.25 1.32
Debt Service Coverage Ratio
329.73 92.72 87.89 62.21 79.56
Interest Coverage Ratio
334.84 249.04 194.16 188.03 244.16
Debt to Market Cap
0.00 <0.01 <0.01 <0.01 <0.01
Interest Debt Per Share
0.74 0.79 0.68 0.39 0.41
Net Debt to EBITDA
-0.04 -1.07 -0.35 -0.07 -0.87
Profitability Margins
Gross Profit Margin
48.21%54.67%34.57%52.05%55.49%
EBIT Margin
15.96%15.39%14.74%14.15%22.46%
EBITDA Margin
17.26%16.84%16.18%15.57%23.36%
Operating Profit Margin
13.19%12.12%11.57%11.03%19.69%
Pretax Profit Margin
15.92%15.35%14.71%14.13%22.34%
Net Profit Margin
11.65%11.28%10.68%10.50%16.57%
Continuous Operations Profit Margin
11.65%11.28%10.68%10.50%16.57%
Net Income Per EBT
73.21%73.53%72.60%74.26%74.18%
EBT Per EBIT
120.65%126.64%127.16%128.17%113.45%
Return on Assets (ROA)
13.16%12.06%12.26%11.00%19.20%
Return on Equity (ROE)
17.60%15.56%15.59%13.70%25.34%
Return on Capital Employed (ROCE)
18.25%16.21%16.41%13.99%29.31%
Return on Invested Capital (ROIC)
13.35%11.89%11.88%10.36%21.65%
Return on Tangible Assets
13.22%12.11%12.34%11.08%19.33%
Earnings Yield
3.69%2.73%2.49%2.37%2.90%
Efficiency Ratios
Receivables Turnover
12.75 8.07 8.80 11.49 10.60
Payables Turnover
4.44 3.23 4.93 3.84 2.99
Inventory Turnover
7.26 8.19 9.54 6.31 6.94
Fixed Asset Turnover
6.64 7.05 8.50 7.98 9.33
Asset Turnover
1.13 1.07 1.15 1.05 1.16
Working Capital Turnover Ratio
4.59 2.09 1.99 1.93 2.20
Cash Conversion Cycle
-3.25 -23.10 5.80 -5.57 -35.23
Days of Sales Outstanding
28.63 45.23 41.50 31.76 34.44
Days of Inventory Outstanding
50.30 44.58 38.28 57.82 52.59
Days of Payables Outstanding
82.18 112.90 73.98 95.14 122.26
Operating Cycle
78.93 89.80 79.78 89.57 87.03
Cash Flow Ratios
Operating Cash Flow Per Share
3.77 17.60 9.62 6.59 17.87
Free Cash Flow Per Share
-2.71 5.31 7.30 3.53 9.84
CapEx Per Share
6.48 12.30 2.32 3.06 8.03
Free Cash Flow to Operating Cash Flow
-0.72 0.30 0.76 0.54 0.55
Dividend Paid and CapEx Coverage Ratio
0.42 1.04 1.39 0.82 1.45
Capital Expenditure Coverage Ratio
0.58 1.43 4.15 2.15 2.22
Operating Cash Flow Coverage Ratio
5.64 24.49 16.15 21.14 59.32
Operating Cash Flow to Sales Ratio
0.02 0.11 0.07 0.05 0.13
Free Cash Flow Yield
-0.51%0.82%1.17%0.61%1.24%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
27.07 36.61 40.16 42.19 34.54
Price-to-Sales (P/S) Ratio
3.15 4.13 4.29 4.43 5.72
Price-to-Book (P/B) Ratio
4.50 5.70 6.26 5.78 8.75
Price-to-Free Cash Flow (P/FCF) Ratio
-196.94 121.26 85.22 163.31 80.77
Price-to-Operating Cash Flow Ratio
141.24 36.56 64.71 87.45 44.46
Price-to-Earnings Growth (PEG) Ratio
1.76 2.73 2.96 -1.04 3.51
Price-to-Fair Value
4.50 5.70 6.26 5.78 8.75
Enterprise Value Multiple
18.24 23.46 26.15 28.38 23.64
Enterprise Value
15.37B 17.80B 17.82B 16.77B 22.38B
EV to EBITDA
18.24 23.46 26.15 28.38 23.64
EV to Sales
3.15 3.95 4.23 4.42 5.52
EV to Free Cash Flow
-196.53 115.98 84.09 162.92 77.90
EV to Operating Cash Flow
140.93 34.97 63.85 87.24 42.88
Tangible Book Value Per Share
117.69 112.36 98.61 98.80 89.98
Shareholders’ Equity Per Share
118.35 112.95 99.43 99.65 90.77
Tax and Other Ratios
Effective Tax Rate
0.27 0.26 0.27 0.26 0.26
Revenue Per Share
168.96 155.80 145.18 130.07 138.82
Net Income Per Share
19.69 17.58 15.50 13.65 23.00
Tax Burden
0.73 0.74 0.73 0.74 0.74
Interest Burden
1.00 1.00 1.00 1.00 0.99
Research & Development to Revenue
<0.01 0.00 0.00 <0.01 <0.01
SG&A to Revenue
0.15 0.26 0.01 0.01 <0.01
Stock-Based Compensation to Revenue
<0.01 0.00 <0.01 <0.01 >-0.01
Income Quality
0.17 1.00 0.62 0.36 0.58
Currency in INR